États-Unis · Bourse & Finance · Yahoo Finance

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Publié par Yahoo Finance · États-Unis il y a 8 h

No. 21 / 2026 Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830 ZP9830 is a novel…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

À lire aussi

Ukraine is making anti-Shahed missiles that have to cost less than $20,000 per shot

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

Oil Prices Slip as Trump-Putin Diesel Deal Raises Supply Hopes

Zcash developers plan a fix to keep ZEC swaps private from future quantum computers

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Partager

À lire aussi

Ukraine is making anti-Shahed missiles that have to cost less than $20,000 per shot

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

Oil Prices Slip as Trump-Putin Diesel Deal Raises Supply Hopes

Zcash developers plan a fix to keep ZEC swaps private from future quantum computers

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’